Clinical Trial Update: Adherence, Improvement Measure (AIM) System [Phase 3]

View source ↗

Summary

The Phase 3 trial evaluating the Adherence, Improvement Measure (AIM) System has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome

Snippet

Sponsor: University of California, San Francisco | Conditions: Patient Compliance, AIDS | Phase 3 | Status: COMPLETED